HUP9903684A2 - Olanzapin alkalmazása depresszió kezelésére szolgáló gyógyszerkészítmények előállítására - Google Patents

Olanzapin alkalmazása depresszió kezelésére szolgáló gyógyszerkészítmények előállítására

Info

Publication number
HUP9903684A2
HUP9903684A2 HU9903684A HUP9903684A HUP9903684A2 HU P9903684 A2 HUP9903684 A2 HU P9903684A2 HU 9903684 A HU9903684 A HU 9903684A HU P9903684 A HUP9903684 A HU P9903684A HU P9903684 A2 HUP9903684 A2 HU P9903684A2
Authority
HU
Hungary
Prior art keywords
olanzapine
preparation
pharmaceutical compositions
treating depression
compositions treating
Prior art date
Application number
HU9903684A
Other languages
English (en)
Inventor
Gary D. Tollefson
Original Assignee
Eli Lilly And Co.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly And Co. filed Critical Eli Lilly And Co.
Publication of HUP9903684A2 publication Critical patent/HUP9903684A2/hu
Publication of HUP9903684A3 publication Critical patent/HUP9903684A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)

Abstract

A jelen találmány tárgya a depresszió kezelésére szőlgáló eljárás,amelynek sőrán az ilyen kezelésre szőrűló betegnek a 2-metil-4-(4-metil-1-piperazinil)-10H-tienő[2,3-b][1,5]benződiazepin-vegyület annakgyógyszerészetileg elfőgadőtt sója vagy szőlvátja hatásős mennyiségétadják be. ŕ
HU9903684A 1995-12-22 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating depression HUP9903684A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US917395P 1995-12-22 1995-12-22
PCT/US1996/019574 WO1997023220A1 (en) 1995-12-22 1996-12-04 Method for treating depression

Publications (2)

Publication Number Publication Date
HUP9903684A2 true HUP9903684A2 (hu) 2000-03-28
HUP9903684A3 HUP9903684A3 (en) 2001-12-28

Family

ID=21736023

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903684A HUP9903684A3 (en) 1995-12-22 1996-12-04 Use of olanzapine for the preparation of pharmaceutical compositions treating depression

Country Status (15)

Country Link
US (1) US5958921A (hu)
EP (1) EP0868185A4 (hu)
JP (1) JP2000502345A (hu)
KR (1) KR19990076689A (hu)
AU (1) AU705834B2 (hu)
CA (1) CA2241153A1 (hu)
CZ (1) CZ198498A3 (hu)
EA (1) EA000745B1 (hu)
HU (1) HUP9903684A3 (hu)
IL (1) IL125031A0 (hu)
MX (1) MX9805064A (hu)
NO (1) NO982911L (hu)
NZ (1) NZ325036A (hu)
PL (1) PL327600A1 (hu)
WO (1) WO1997023220A1 (hu)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0796619A1 (en) 1996-03-21 1997-09-24 Merrell Pharmaceuticals Inc. Use of (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol in treating depressive disorders and bipolar disorders
US5968921A (en) 1997-10-24 1999-10-19 Orgegon Health Sciences University Compositions and methods for promoting nerve regeneration
US6960577B2 (en) 1998-05-22 2005-11-01 Eli Lilly And Company Combination therapy for treatment of refractory depression
US6121259A (en) * 1998-11-23 2000-09-19 Sepracor Inc. Olanzapine-N-oxide compositions and methods
JP2002530339A (ja) 1998-11-23 2002-09-17 セプラコール， インク． ２−ヒドロキシメチルオランザピン組成物及び方法
ATE286398T1 (de) 1998-11-23 2005-01-15 Sepracor Inc Desmethylolanzapine enthaltende zusammensetzungen und verfahren
WO2004010932A2 (en) * 2002-07-30 2004-02-05 Peter Migaly Combination therapy for depression, prevention of suicide, and varous medical and psychiatric conditions
AR042806A1 (es) * 2002-12-27 2005-07-06 Otsuka Pharma Co Ltd Combinacion de derivados de carboestirilo e inhibidores de la reabsorcion de serotonina para el tratamiento de trastornos del animo
DK1575590T3 (da) 2002-12-27 2008-02-11 Otsuka Pharma Co Ltd Carbostyrilderivater og serotoningenoptagelsesinhibitorer til behandling af sindsstemningslidelser
US20050181071A1 (en) * 2004-02-18 2005-08-18 Binder Michael R. Method for the treatment of clinical depression
WO2014021804A1 (en) 2012-07-31 2014-02-06 Sanovel Hayvan Sagligi Ürünleri Sanayi Ve Ticaret A.S. A method for increasing meat and milk production
EA201590048A1 (ru) 2012-07-31 2015-09-30 Сановел Хайван Саглиги Юрюнлери Санайи Ве Тиджарет А.С. Применение оланзапина у животных
WO2014078568A1 (en) 2012-11-14 2014-05-22 The Johns Hopkins University Methods and compositions for treating schizophrenia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8605504D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel chroman derivatives
US5229382A (en) * 1990-04-25 1993-07-20 Lilly Industries Limited 2-methyl-thieno-benzodiazepine
US5605897A (en) * 1991-04-23 1997-02-25 Eli Lilly And Company 2-methyl-thieno-benzodiazepine

Also Published As

Publication number Publication date
NO982911D0 (no) 1998-06-22
EA199800590A1 (ru) 1998-12-24
CZ198498A3 (cs) 1999-03-17
EP0868185A1 (en) 1998-10-07
JP2000502345A (ja) 2000-02-29
AU1284797A (en) 1997-07-17
HUP9903684A3 (en) 2001-12-28
NO982911L (no) 1998-06-22
AU705834B2 (en) 1999-06-03
KR19990076689A (ko) 1999-10-15
IL125031A0 (en) 1999-01-26
EA000745B1 (ru) 2000-02-28
EP0868185A4 (en) 2002-04-10
WO1997023220A1 (en) 1997-07-03
CA2241153A1 (en) 1997-07-03
MX9805064A (es) 1998-10-31
US5958921A (en) 1999-09-28
NZ325036A (en) 2001-06-29
PL327600A1 (en) 1998-12-21

Similar Documents

Publication Publication Date Title
TW372872B (en) Thieno[1,5]benzodiazepine use
YU73991A (sh) POSTUPAK ZA DOBIJANJE 2-METIL-10-(4-METIL-1-PIPERAZINIL)-4H- TIENO 2,3-b 1,5 BENZODIAZEPINA
HUP9903684A2 (hu) Olanzapin alkalmazása depresszió kezelésére szolgáló gyógyszerkészítmények előállítására
HUP9800410A2 (hu) Szájon át adható 2-metil-tieno-benzodiazepin-készítmény
TNSN98111A1 (fr) Tartrate d'un dipeptide substitue, procede pour sa preparation et compositions pharmaceutiques le contenant.
ATE229335T1 (de) Heterozyklische bizykeln zur behandlung von impotenz
HUP9802824A3 (en) Novel crystal form of the 2-methyl-4-(4-methyl-1-piprezinyl)-10h-thieno[2,3-b][1,5]benzodiazepine and process for its preparation
HUP0302114A2 (hu) Eritropoietin-fehérjét tartalmazó folyékony gyógyászati készítmény, eljárás előállítására és alkalmazása
FR2733750B1 (fr) Derives de l'acide gamma-oxo-alpha-(phenylmethyl)-5,6- dihydro-4h-thieno(3,4-c)pyrrole-5-butanoique, leur preparation et leur application en therapeutique
IL117971A (en) Pharmaceutical compositions containing olanzapine for treating dyskinesias
NZ332037A (en) Olanzapine for treating migraine pain
TW429149B (en) Pharmaceutical composition for treating conditions resulting from the cessation and withdrawal from the use of nicotine
ES2185777T3 (es) Tratamiento de la anorexia.
EP0911028A3 (en) Method for treating sexual dysfunction
HUP9903688A2 (hu) Olanzapin alkalmazása az autizmus kezelésére szolgáló gyógyszerkészítmény előállítására
MX9707936A (es) Compuestos para tratar disfunciones del conocimiento.
HUP9903679A2 (hu) Olanzapin alkalmazása bipoláris zavar kezelésére szolgáló gyógyszerkészítmények előállítására
NO984196L (no) FremgangsmÕte for behandling av stoffmisbruk
HUP9902882A2 (hu) Olanzapin alkalmazása álmatlanság kezelésére szolgáló gyógyszerkészítmények előállítására
YU40198A (sh) Postupak za tretiranje zavisnosti od supstance